KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) FCF Margin (2016 - 2025)

Eli Lilly's FCF Margin history spans 17 years, with the latest figure at 3.51% for Q4 2025.

  • For Q4 2025, FCF Margin fell 371.0% year-over-year to 3.51%; the TTM value through Dec 2025 reached 13.77%, up 542.0%, while the annual FY2025 figure was 13.77%, 542.0% up from the prior year.
  • FCF Margin reached 3.51% in Q4 2025 per LLY's latest filing, down from 38.34% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 38.34% in Q3 2025 to a low of 14.79% in Q4 2023.
  • Average FCF Margin over 5 years is 13.01%, with a median of 14.05% recorded in 2023.
  • Peak YoY movement for FCF Margin: crashed -3070bps in 2023, then surged 2201bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 24.63% in 2021, then plummeted by -35bps to 15.91% in 2022, then crashed by -193bps to 14.79% in 2023, then skyrocketed by 149bps to 7.22% in 2024, then crashed by -51bps to 3.51% in 2025.
  • Per Business Quant, the three most recent readings for LLY's FCF Margin are 3.51% (Q4 2025), 38.34% (Q3 2025), and 8.93% (Q2 2025).